Reletter
Artwork for Zendudest’s Substack

Zendudest’s Substack

Zendudest

My personal Substack

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues58Foundeda year agoLast Issue3 days ago
Active

Read this Newsletter

zendudest.substack.com
Artwork for Zendudest’s Substack

Latest Issues

From yeast to humans

In the early 1990’s my lab was devoted to understanding how clozapine achieved it’s remarkable efficacy in treatment-resistant schizophrenia and I was fortunate enough to be recruited to CWRU by Herbert Yale Meltzer (don’t you love his midd...

3 days ago
8
1

The joys of being a CRO for the NIH: Part 2

So to continue…by virtue of what I now recognize as a grand cosmic joke my lab was fortunate enough to obtain our FIRST NIH CONTRACT in 1998. Per his promise my former chair—the amazing Richard Hanson (may his memory be a blessing)—gave me...

11 days ago
5
1

Why you should consider being a CRO for the NIH: Part 1

My decades of zen training have alerted me to a “disturbance in the force” related to a recent exhortation regarding scientific excellence and the role of government in acclerating discoveries where they highlight the potential/real advanta...

19 days ago
12

When do I use AI and why?

As I mentioned previously, AI shows promise for therapeutic drug discovery in terms of ligand discovery and design, but will have challenges related to predicting clinical trial results and indications.

My lab uses AI-esque approaches con...

a month ago
5
1

What is pharmacology?

Here at UNC we are in the midst of a search for a new Chair for the Department of Pharmacology. In fairness to the applicants, I’ll not comment on anything related to their presentations. I note that all are required to present a ‘Vision fo...

a month ago
10
6

Key Facts

Contact Information
Newsletter Author
Number of Subscribers
Find out how many people subscribe to this newsletter.

Audience Metrics

Subscribers, engagement, traffic and sponsorship for Zendudest’s Substack.

SubscribersEngagement72Monthly Web Visits
Accepts SponsorsEstimated Cost per Ad

Authors

The writers behind this newsletter.

  • Zendudest
  • Frequently Asked Questions

    How can I access the email archive for Zendudest’s Substack?

    You can find recent issues that have been published by Zendudest’s Substack on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Zendudest’s Substack have?

    To see how many people subscribe to Zendudest’s Substack, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Zendudest’s Substack?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Zendudest’s Substack as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Zendudest’s Substack?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Zendudest’s Substack using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters related to Zendudest’s Substack?

    Scroll up to where it says Related Newsletters to see other publications like Zendudest’s Substack. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Zendudest’s Substack?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.